Fig. 2From: Kinetics of CD169, HLA-DR, and CD64 expression as predictive biomarkers of SARS-CoV2 outcomeExpression of neutrophil CD64 at disease onset and during the follow-up. A mild upregulation of neCD64 is observed in the majority of patients, while very high values were detectable only in patients with overt bacteremia and sepsisBack to article page